MedPath

A phase II study of percutaneous trans-esophageal gastric tubing for malignant gastrointestinal obstruction (JIVROSG-0205)

Phase 2
Conditions
Malignant gastrointestinal obstruction
Registration Number
JPRN-C000000042
Lead Sponsor
Japan Interventional Radiology in Oncology Study Group (JIVROSG)
Brief Summary

Technical success rate: 100% Average required time for procedure: 28.5 min Clinical efficacy: 91% Mortality within 30 days: 5 (All caused by progression of primary disease) Procedure related Adverse events (>Grade 2): Broncho-esophageal fistula

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
33
Inclusion Criteria

Not provided

Exclusion Criteria

1) Tracheostomy. 2) Intestinal obstruction due to the lesions between transverse colon and rectum. 3) Pregnancy. 4) Local therapy for neck region

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement of subjective symptoms compared to previous nasal tubing.
Secondary Outcome Measures
NameTimeMethod
Adverse events and feasibility of procedure
© Copyright 2025. All Rights Reserved by MedPath